PEAK6 Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,400
Closed -$47K 4802
2018
Q1
$47K Buy
+1,400
New +$53.7K ﹤0.01% 3979
2016
Q1
Sell
-9,500
Closed -$489K 4886
2015
Q4
$489K Buy
9,500
+8,000
+533% +$397K ﹤0.01% 2616
2015
Q3
$68K Sell
1,500
-600
-29% -$28.3K ﹤0.01% 4532
2015
Q2
$97K Buy
+2,100
New +$91.9K ﹤0.01% 4268
2014
Q4
Sell
-5,600
Closed -$181K 5019
2014
Q3
$181K Buy
+5,600
New +$187K ﹤0.01% 3394
2014
Q2
Sell
-12,600
Closed -$343K 4996
2014
Q1
$343K Sell
12,600
-400
-3% -$11.9K ﹤0.01% 2894
2013
Q4
$465K Buy
+13,000
New +$432K ﹤0.01% 2722

Other funds holding PBH

PEAK6 Group's PBH Position: Q2 2018 in Review

PEAK6 Group sold out of Prestige Consumer Healthcare (PBH) in Q2 2018, closing a stake of 3,742 shares — an estimated $126K sold.

PEAK6 Group first reported a position in PBH in Q1 2014 and held it in 2 quarters. The position peaked at $126K in Q1 2018. 237 funds tracked by Wall St. Rank hold PBH as of Q2 2018.

  • PEAK6 Group reported no remaining Prestige Consumer Healthcare position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 3,742 Prestige Consumer Healthcare shares in Q2 2018, an estimated $126K.
  • PEAK6 Group first reported a position in Prestige Consumer Healthcare in Q1 2014 and held it in 2 quarters.
  • PEAK6 Group's Prestige Consumer Healthcare position peaked at $126K in Q1 2018.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.